العربية
Hama Pharma received a delegation of doctors from Hama Governorate and its countryside to talk about Simvatrol medicine.
Where Dr. Zuhair Fedda, an endocrinologist, gave a lecture entitled:
“Control of dyslipidemia to reduce CVD in diabetes”.
Dr. Marina Al-Halabi, Director of Research and Development at Hama Pharma Company, also gave a presentation entitled:
“Rovaltro = Quality”
To talk about the most importantmanufacturing features of Rovaltro, which make it unique and undisputed.
The lecture was followed by a dinner party.
